These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6918176)
21. [Effect on the eye vessels of vasodilator agents after their administration by different electrophoretic methods (clinical study)]. Nurieva SM Vestn Oftalmol; 1978; (2):71-3. PubMed ID: 349832 [No Abstract] [Full Text] [Related]
22. [Use of citrate nicamétate at high doses in cardiovascular surgery]. Stankowiak C; Vandecasteele J; Soots G Lille Med; 1973 Nov; 18(9):1039-42. PubMed ID: 4211730 [No Abstract] [Full Text] [Related]
23. [The EEG in the treatment of hypoxic diseases and other diseases of brain by vasoactive drugs]. Flügel KA Rev Neurol (Paris); 1967 Jul; 117(1):94-7. PubMed ID: 6063890 [No Abstract] [Full Text] [Related]
24. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment. Kumar N; Griffiths B; Allen J J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964 [No Abstract] [Full Text] [Related]
25. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs]. Bollinger A; Lüthy E Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297 [No Abstract] [Full Text] [Related]
32. [Piascledine in the treatment of scleroderma]. Szczepański A; Dabrowska H; Moskalewska K Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404 [No Abstract] [Full Text] [Related]
33. [Treatment of systemic scleroderma with fucidin in relation to clinical evaluation and analysis of free amino acids in the serum]. Rubisz-Brzezińska J; Zebracka T; Mozdzanowska K; Mozdzanowski J Przegl Dermatol; 1986; 73(4):305-11. PubMed ID: 3333865 [No Abstract] [Full Text] [Related]
34. [Dermatological experience with dimethyl sulfoxide (DMSO)]. Weitgasser H Z Haut Geschlechtskr; 1967 Sep; 42(18):749-54. PubMed ID: 5591425 [No Abstract] [Full Text] [Related]
35. [Dimethylsulfoxide in the treatment of organic forms of scleroderma]. Sergeev VP Sov Med; 1975 Aug; (8):154-5. PubMed ID: 1233753 [No Abstract] [Full Text] [Related]
36. Comparison of alpha-tocopheryl nicotinate and acetate on skin microcirculation. Kamimura M Am J Clin Nutr; 1974 Oct; 27(10):1110-6. PubMed ID: 4417850 [No Abstract] [Full Text] [Related]
37. [The local therapy of systemic scleroderma]. Guseva NG Ter Arkh; 1990; 62(5):110-3. PubMed ID: 2396204 [No Abstract] [Full Text] [Related]
38. [Madecassol in the treatment of scleroderma (preliminary study)]. Szczepański A; Dabrowska H; Blaszczyk M Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170 [No Abstract] [Full Text] [Related]
39. [Treatment of systemic scleroderma with D-penicillin]. Ivanova MM; Guseva NG; Balabanova RM; Oskilko TG Ter Arkh; 1977; 49(11):91-9. PubMed ID: 605409 [No Abstract] [Full Text] [Related]
40. Thrombotic events in patients with systemic sclerosis treated with iloprost. Tedeschi A; Meroni PL; Del Papa N; Salmaso C; Boschetti C; Miadonna A Arthritis Rheum; 1998 Mar; 41(3):559-60. PubMed ID: 9506585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]